A bitter pill

[This post is based on the editorial in the May issue – read here for the full text, available for free to all registered users. We welcome feedback on our editorials in the comments section below.]

Cuts in pharmaceutical R&D jobs might provide short-term improvements to the bottom line, but do not bode well for the industry in the long run.

Right now does not seem to be a good time to be a pharmaceutical researcher. In January and February this year some of the world’s biggest pharmaceutical companies seemed to be competing to see who could lay off the most staff. The background to all of this is the low numbers of compounds that the companies have in their pipelines and the soon-to-expire patents of their highest selling drugs. The drug companies’ response has been the same for several years — merge and try to make cost savings.

So where is the industry headed? Are we witnessing a wholesale restructuring of the way these companies perform research? For many years, the large pharma companies have been outsourcing parts of their R&D. It is often the same scientists who used to work directly for big pharma who now work at (and run) the contract research organisations.

Smaller salaries and less regulation are an easy way to cut costs. It is thus no surprise that the only part of GSK neuroscience research to survive the cuts is the neurodegeneration area based in Shanghai. Another option has been to in-license drugs developed by smaller companies. The approach is popular — it removes much of the risk from the early stages of development.

There seems to be a fundamental problem with either approach. Big pharma has always played a role as a training ground in medicinal chemistry. Furthermore, having experts within the company is absolutely necessary and taking part in ongoing research is a major part of that expertise. For evidence of the problems with in-licensing, one needs to look no further than the ongoing uncertainty over the GSK deal for Sirtris.

Big pharma and small start-up companies might have very different criteria for taking a drug candidate into clinical trials. Clinical trials are a costly venture and big pharma must see a reasonable chance of positive results before proceeding. For start-ups simply reaching this stage might be enough to bring in the buyers.

Whether this is a short-term lull in the industry, or whether it is a sign of things to come, it is important to consider what these vast numbers of trained chemists will now do. Governments worldwide repeat calls for more science graduates — and in many ways it’s not the new graduates who have the problem. The typical pharma job advert seeks a PhD graduate with 0-5 years of experience — so the really bad news is for those more experienced chemists who have just been laid off.

It would now seem to be a tough task to convince a potential graduate student that this industry is so attractive. Who would invest years of their life and a lot of money into gaining a graduate degree if it offered only five years of employment before forcing a complete career change?

Our latest issue…

…has just gone live. You can find it here.

It features: a pretty eye-catching cover, a PHD cartoon in the Thesis article on making science experiments more public and a review of the fun but dangerous-sounding book Mad Science: Experiments You Can Do at Home — But Probably Shouldn’t.

This month’s research papers cover carbene-stabilised P2 radical ions, intefacial structure rearrangements induced by charge-transfer, some synergistic organocatalysis, organic redox electrolytes for solar cells and much more.

And don’t forget to check out the atomic-emission-spectra scarves mentioned in Blogroll too!

Neil

Neil Withers (Associate Editor, Nature Chemistry)

Reactions – Nongjian (NJ) Tao

Nongjian (NJ) Tao is in the Center for Bioelectronics and Biosensors, Biodesign Institute, and also affiliated with Electrical Engineering, Physics and Chemistry at Arizona State University. His current research interests include molecular electronics, chem- and bio-sensors.

1. What made you want to be a chemist?

I am probably not a typical chemist on Nature Chemistry’s blog because my training is in biophysics. I have been attracted to chemistry because it serves as glue between physics, biology and engineering, which is critically important for interdisciplinary research, such as molecular electronics and sensors.

2. If you weren’t a chemist and could do any other job, what would it be – and why?

I would like to be a geologist or astronaut, who can explore new frontiers, a remote desert or a distant planet, while getting paid. I don’t really regret my career decision because I find that exploring research areas between different traditional disciplines is just as exciting (and challenging).

3. What are you working on now, and where do you hope it will lead?

I am looking for ways to place a single molecule between electrodes, to probe and control its chemical and physical properties, and to explore device applications. I am also developing chemical sensors that can fit in a cell phone, allowing one to excess not only internet and email, but also chemical information. I believe that such a function would expand our capability to solve many real world problems, such as security, environmental protection, and disease prevention and diagnosis.

4. Which historical figure would you most like to have dinner with – and why?

Richard Feynmann would be at the top of a long list. “Feynmann’s Lectures in Physics” helped me to pass an important Physics exam that sent me to study for a Ph.D. in the US. “Surely, you’re joking, Mr. Feynmann” once made a 12-hour oversea flight quite enjoyable and unforgettable. His “plenty of room” lecture has been a constant source of inspiration for my research.

5. When was the last time you did an experiment in the lab – and what was it?

That was last week – when I was experimenting three different glues to fix my broken glasses. Over time, I find myself spending less time doing lab work, and more time reviewing or writing proposals. Fortunately, I am surrounded by many young talents who can do better jobs in lab than myself.

6. If exiled on a desert island, what one book and one music album would you take with you?

I will bring books that can teach me how to survive in a desert island or break out of prison. Entertaining books and CDs would be nice, but I would have to save the space for water and food.

7. Which chemist would you like to see interviewed on Reactions – and why?

Stuart Lindsay – my Ph.D. mentor. He taught me how to do science. I am sure that younger readers will benefit from interacting with him.

Reactions – Junichiro Yamaguchi

Junichiro Yamaguchi is in the Department of Chemistry at Nagoya University, and works on the synthesis of biologically active molecules and natural products – particularly through C-H bond functionalization. Discovery and development of new chemical reactions in order to aim for the “ideal organic synthesis” are his ultimate goals. He also co-runs Chem-Station, a famous chemistry website in Japan.

1. What made you want to be a chemist?

When I first entered university, I had absolutely no interest in chemistry. However, I am fortunate to have met Prof. Yujiro Hayashi at the time, who completely changed my mind and who eventually became my Ph.D. supervisor. He had an unusual, almost excessive passion for chemistry, and particularly for organic chemistry, which he seemed to enjoy purely out of curiosity. I simply started chemistry in order to try to see what he thought was so incredibly interesting – by that time, his passion had already transferred onto me!

2. If you weren’t a chemist and could do any other job, what would it be – and why?

I guess I would be a salesman of some business or medical firm because I am drawn by the strength of interpersonal communication, and I think that selling merchandise is based on trust and relationships between people. In this vein, I am also interested in working on the World Wide Web. I would have set up an independent online-based company, although I cannot tell if such a plan would have enjoyed success or not.

3. What are you working on now, and where do you hope it will lead?

I am working as an Assistant Professor with Prof. Kenichiro Itami in chemical synthesis. I have partaken in natural product total synthesis, and I have been fortunate enough to be involved in the synthesis of many bioactive natural products during my graduate and postdoctoral research. However, natural product synthesis requires so many complex strategies, such that only fellow scientists in this field could understand the extent of its tortuous and complex nature. In order to realize the “ideal chemical synthesis”, the main emphasis of my research regards the development of new synthetic methods, strategies, and concepts to solve challenging synthetic problems. I would like to make molecules as if one were to construct architectures using LEGO blocks.

4. Which historical figure would you most like to have dinner with – and why?

I would like to have dinner with Prof. Robert Woodward, widely recognized as the best synthetic chemist of the 20th century. Having achieved such tremendous total syntheses in an age when purification techniques and spectroscopic analyses were so limited, is nothing short of extraordinary. I would like to talk to him about chemical synthesis and the future of the field of organic chemistry.

5. When was the last time you did an experiment in the lab – and what was it?

I am still running experiments routinely in the lab, and trying to share time with my students in the fumehood. Therefore, I cannot even conceptualize the last experiment I could run, and in fact I do not even want to think about it! Over time, my efforts in the fumehood will have to be gradually reduced, but I would like to keep doing chemistry with my own hands as much as possible.

6. If exiled on a desert island, what one book and one music album would you take with you?

Could I cheat and bring a laptop, or at least an iPhone? If I had to be disconnected from the world, I would simply like to enjoy various pieces of literary works and music, as well as various scientific papers, little by little, until the end of time.

7. Which chemist would you like to see interviewed on Reactions – and why?

I actually have two chemists in mind – the first one is Prof. Phil Baran of The Scripps Research Institute, my postdoc advisor as well as good friend. He is only one year older than me, and yet his ability to synthesize natural products keeps astonishing the chemical community. The second chemist would be Prof. Kenichiro Itami, who I currently share my days with. I would have refused to go back to Japan for my career had I not had the opportunity to meet him and if he did not have such a splendid personality and intellectual talent.

Materials Girl: Conference etiquette

[Posted on behalf of Materials Girl, who is blogging from the Spring 2010 Materials Research Society meeting.]

There often exists an unfortunate lack of connection between presenter and audience. What with non-native English speakers – bless them – insufficient amplification, convoluted PowerPoint, and all the rest, we all may find ourselves itching to be at another symposium. Unfortunately, leaving mid-talk constitutes disruption and some insult to the presenter. (I’ve made it a habit to sit unobtrusively in a corner, and to only sneak out of large, full rooms when the speaker’s back is turned.)

This introduces the subject of attendee etiquette. Half of the audience may walk in late or leave midway through a presentation, although that can be excused in light of travel considerations, lack of personal relevancy, etc. Much less forgivable is the making of excess noise during talks, or squeezing past people to reach a seat near the front. (It’s really not hard to stay in the back, and to wait until questions are finished to move around! Most people do, but occasionally someone bustles about loudly.) Perhaps the worst offence is maintaining noisy conversations outside in the hall, or even in the room. The perpetrators’ voices might be at their normal speaking volume, but everything is loud to the audience of a silent room. All of these annoyances can be avoided with a little bit of consideration…

We might also consider direct interaction, where occasionally some poor young graduate gets ripped apart by a cantankerous researcher, or a combative questioner harasses speakers over minor details. Probing questions and challenging ideas are helpful, but personal/professional/political issues are best left for private debate! As Tim Miller noted in his excellent seminar, Mastering Science Presentations, it is best for all parties to maintain complete civility and to firmly disregard unscientific impoliteness.

On another note, the clothing ranges from business suits and dress shirts, to jeans and t-shirts – sometimes even flip flops! Personally, it feels awkward to wear anything short of a black coat, slacks, heels/boots, etc. (So I generally resemble a character from the Matrix. Or a dude.) Attire is a minor issue, though, particularly since most attendees are males whose formalwear is relatively comfortable and easily come by.

So, considering general dress and behavior (aside from interpersonal relations), conference etiquette boils down to a major question: how stiff and formal are we expected to be?

Nuclear research: Elusive element 117 created

So far, up to the atomic number 118, only one element had yet to be produced — element 117, temporarily referred to as ‘ununseptium’. Yuri Oganessian and colleagues in Russia and the US have now announced doing just this, in a paper accepted on Monday in Physical Review Letters.

By bombarding the actinide berkelium (Bk-249 that has 97 protons and 152 neutrons) with calcium (Ca-48, with 20 protons and 28 neutrons), the team has produced 2 different isotopes of the elusive element 117: ‘117’-294, with a half-life of 78 milliseconds, ‘117’-293 with a half-life of 14 milliseconds, as ScienceNews explains.

Despite these very short half-lives, the authors mention that the decaying properties of element 117 support the existence of the famous ‘Island of Stability’, an area of the periodic table where superheavy elements – which normally decay extremely rapidly – are predicted to have extra stability, conferred by the arrangement of their nucleons in closed shells.

Only a couple of months after element 112 was officially named copernicium, which Neil had told us about here, it looks like the IUPAC will be kept busy pondering on a name and symbol for ‘ununseptium’.

Anne

Anne Pichon

(Associate Editor, Nature Chemistry)

Rhyming research

Great science is not easily recognized without good writing skills. In view of this, we have decided to introduce a new prerequisite for the consideration of manuscripts at Nature Chemistry: Authors are requested to include a short poem highlighting the novel conclusions of their work. (Special consideration will be given to those who prepare their entire manuscript in iambic pentameter.)

This new submission requirement will be in effect from the date of this blog post.

Steve

Stephen Davey (Associate Editor, Nature Chemistry)